Canada reports second case of blood clotting linked to AstraZeneca's COVID-19 vaccine
Canada reported the second case of rare but serious blood clotting linked to AstraZeneca's COVID-19 vaccine.
Canadian health officials stated that they recorded the first case of blood clotting associated with low platelets on Tuesday.
"Blood clot formations linked to the AstraZeneca vaccine remain very rare and Canada still believes that the vaccine's benefits outweigh the potential risks," Health Canada and the Public Health Agency of Canada said.
Denmark also reported cases regarding blood clots among those that had received the jab and has stopped using the vaccine.
Canada, however, still recommend the shot for use.
(Edited by Ladiangti Rani)
TNT-The Northeast Today is now on WhatsApp: CLICK HERE to receive more updates on your phone.